Aller au contenu principal
Accès ouvert déclaré 2019 article

Genome-wide association study of germline variants and breast cancer-specific mortality

72Citations signalées, ce qui n’est pas une note de qualité
169Institutions déclarées
23Pays d’affiliation déclarés

Rattachement africain : nl, gb, de, au, ca, us, es, ru, fi, se, be, dk, it, no, sa, fr, gr, pl, ie, il, cn, pt, co. Niveau de preuve : code pays fourni par la source.

Le résumé fourni par la source

BACKGROUND: We examined the associations between germline variants and breast cancer mortality using a large meta-analysis of women of European ancestry. METHODS: Meta-analyses included summary estimates based on Cox models of twelve datasets using ~10.4 million variants for 96,661 women with breast cancer and 7697 events (breast cancer-specific deaths). Oestrogen receptor (ER)-specific analyses were based on 64,171 ER-positive (4116) and 16,172 ER-negative (2125) patients. We evaluated the probability of a signal to be a true positive using the Bayesian false discovery probability (BFDP). RESULTS: , HR = 1.27, 95% CI = 1.16-1.39); located within a long intergenic non-coding RNA gene (AC004009.3), close to the HOXA gene cluster. CONCLUSIONS: We uncovered germline variants on chromosome 7 at BFDP < 15% close to genes for which there is biological evidence related to breast cancer outcome. However, the paucity of variants associated with mortality at genome-wide significance underpins the challenge in providing genetic-based individualised prognostic information for breast cancer patients.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Le contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref
Genome-wide association study of germline variants and breast cancer-specific mortality
Date Crossref
21/02/2019
Éditeur
Springer Science and Business Media LLC
Type
journal-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.

Les institutions déclarées

The Netherlands Cancer InstituteUniversity of CambridgeMedizinische Hochschule HannoverQIMR Berghofer Medical Research InstituteCambridge University Hospitals NHS Foundation TrustCancer Research UK Cambridge CenterNIHR Cambridge Biomedical Research CentreMount Sinai HospitalUniversity of TorontoLunenfeld-Tanenbaum Research InstituteUniversity of California, IrvineGerman Cancer Research CenterHeidelberg UniversityFred Hutch Cancer CenterUniversity of Wisconsin–MilwaukeeUniversitätsklinikum ErlangenMilwaukee Health DepartmentComprehensive Cancer Center ErlangenSpanish National Cancer Research CentreCentre for Biomedical Network Research on Rare DiseasesRussian Academy of SciencesInstitute of Biochemistry and Genetics of Ufa Scientific CentreCity of HopeBeckman Research InstituteUniversity of HelsinkiHelsinki University HospitalÖrebro University HospitalVIB-KU Leuven Center for Cancer BiologyKU LeuvenUniversity of CopenhagenCopenhagen University HospitalGentofte HospitalEuropean Institute of OncologyOslo University HospitalUniversity of OsloAkershus University HospitalVestre Viken Hospital TrustDr. Margarete Fischer-Bosch-Institute of Clinical PharmacologyDeutsches Konsortium für Translationale KrebsforschungUniversity of TübingenNational Center for Tumor DiseasesQueen Mary University of LondonNational Cancer InstituteDivision of Cancer Epidemiology and GeneticsLund UniversityUniversity of SheffieldInstitute of Cancer ResearchInstituto de Investigación Sanitaria del Hospital Clínico San CarlosCentro de Investigación Biomédica en Red de CáncerUniversity of PisaKing Abdulaziz UniversityUniversidade de Santiago de CompostelaFundación Pública Galega de Medicina XenómicaInstituto de Investigación Sanitaria de SantiagoServicio Gallego de SaludAmerican Cancer SocietyUniversität HamburgUniversity Medical Center Hamburg-EppendorfUniversity Cancer Center HamburgRoswell Park Comprehensive Cancer CenterThe University of SydneyWestmead Institute for Medical ResearchInsermCentre de recherche en Epidémiologie et Santé des PopulationsMayo ClinicCentre de Recherche en Cancérologie de LyonMayo Clinic in ArizonaImperial College LondonKarolinska InstitutetFox Chase Cancer CenterLeiden University Medical CenterUniversity of WarwickUniversity of SouthamptonUniversity of WestminsterBrigham and Women's HospitalHarvard UniversityLeipzig UniversityManchester Academic Health Science CentreUniversity of ManchesterSt Mary's HospitalEdinburgh Cancer ResearchUniversity of EdinburghUniversity of California San DiegoRoyal Marsden NHS Foundation TrustUniversity Hospital of HeraklionThe University of MelbourneCancer Council VictoriaMonash UniversityMelbourne HealthUniversity of UtahHuntsman Cancer InstituteOulu University HospitalUniversity of OuluUniversity of CologneUniversity Hospital CologneUniversity of Southern CaliforniaStockholm South General HospitalUniversity of Massachusetts AmherstAmherst CollegeManchester University NHS Foundation TrustWythenshawe HospitalNIHR Manchester Biomedical Research CentreMayo Clinic in FloridaUniversity of Eastern FinlandKuopio University HospitalKrebsregister SaarlandErasmus MC Cancer InstituteCancer Research UK Manchester InstituteUniversity of OxfordCancer Prevention Institute of CaliforniaStanford UniversityStanford Health CareTampere University HospitalTampere UniversityPomeranian Medical UniversityNational University of IrelandBashkir State UniversityPublic Health OntarioSinai Health SystemJohanniter-Krankenhaus BonnUniversity of Hawaiʻi at MānoaUniversity of Hawaii SystemCancer Center of HawaiiUniversity of Hawaii Cancer CenterCarmel Medical CenterTianjin Medical University Cancer Institute and HospitalUniversity of WashingtonSeattle UniversityThe Maria Sklodowska-Curie National Research Institute of OncologyGerman Breast GroupFondazione IRCCS Istituto Nazionale dei TumoriKarolinska University HospitalThe Alfred HospitalLudwig-Maximilians-Universität MünchenUniversity Health NetworkSorbonne Paris CitéUniversity of California, DavisQueen's University BelfastUniversity of New MexicoHospital Monte NarancoHospital Universitario Puerta de Hierro MajadahondaIFOMGuy's HospitalKing's College LondonKing's College HospitalNordLabUniversity Hospital of LarissaCase Western Reserve UniversityJohn Hunter HospitalHunter Medical Research InstituteUniversity of Newcastle AustraliaCentre hospitalier universitaire de QuébecUniversité LavalCentre hospitalier de l'Université LavalMonash HealthBC Cancer AgencyUniversity of British ColumbiaVancouver General HospitalUniversidade do PortoInstituto Português de Oncologia Francisco GentilColumbia UniversityLeiden UniversityCentre for Human GeneticsUniversity of BirminghamPontificia Universidad JaverianaKlinikum MittelbadenOlgahospitalHelios Hospital Berlin-BuchUniversity of California, Los Angeles

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Les sujets associés

BRCA gene mutations in cancerGenetic Associations and EpidemiologyGenomics and Rare Diseases

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.